SCI时时刷

search
Comparative assessment of breast volume using a smartphone device versus MRI
Comparative assessment of breast volume using a smartphone device versus MRI
Assessment of breast volume has a relevance for aesthetic surgery and for the prevention and prediction of breast diseases...
Development and validation of a predictive risk tool for VTE in women with breast cancer under chemotherapy: a cohort study in China
Development and validation of a predictive risk tool for VTE in women with breast cancer under chemotherapy: a cohort study in China
The incidence of venous thromboembolism (VTE) is significantly elevated in breast cancer patients, with a three-to-fourfol...
Hub metastatic gene signature and risk score of breast cancer patients with small tumor sizes using WGCNA
Hub metastatic gene signature and risk score of breast cancer patients with small tumor sizes using WGCNA
Breast cancer (BC) is the most common cancer in women and accounts for approximately 15% of all cancer deaths among women ...
Applying whole-genome and whole-exome sequencing in breast cancer: a review of the landscape
Applying whole-genome and whole-exome sequencing in breast cancer: a review of the landscape
Whole-genome sequencing (WGS) and whole-exome sequencing (WES) are crucial within the context of breast cancer (BC) resear...
Mirror therapy for patients with breast cancer: A systematic review and meta-analysis
Mirror therapy for patients with breast cancer: A systematic review and meta-analysis
Pain and dysfunction of the shoulder and arm are prevalent among patients with breast cancer. This review aimed to evaluat...
A genome-wide CRISPR/Cas9 knockout screen identifies SEMA3F gene for resistance to cyclin-dependent kinase 4 and 6 inhibitors in breast cancer
A genome-wide CRISPR/Cas9 knockout screen identifies SEMA3F gene for resistance to cyclin-dependent kinase 4 and 6 inhibitors in breast cancer
Palbociclib is a cell-cycle targeted small molecule agent used as one of the standards of care in combination with endocri...
Integrin β1 in breast cancer: mechanisms of progression and therapy
Integrin β1 in breast cancer: mechanisms of progression and therapy
The therapy for breast cancer (BC), to date, still needs improvement. Apart from traditional therapy methods, biological t...
Desire for pregnancy and fertility preservation in young patients with breast cancer
Desire for pregnancy and fertility preservation in young patients with breast cancer
Data on the desire for pregnancy and the status of fertility preservation (FP) in patients with breast cancer remain uncle...
Clinicopathological and prognostic features of HER2-null and HER2-low advanced breast cancer treated with eribulin or capecitabine
Clinicopathological and prognostic features of HER2-null and HER2-low advanced breast cancer treated with eribulin or capecitabine
HER2-low populations constitute a heterogeneous group, and the cytotoxic anticancer agent efficacy based on HER2 status re...
Increasing survivors of anthracycline-related cardiomyopathy with breast cancer in trastuzumab era: thirty-one-year trends in a Japanese Community
Increasing survivors of anthracycline-related cardiomyopathy with breast cancer in trastuzumab era: thirty-one-year trends in a Japanese Community
Trastuzumab has improved breast cancer (BC) prognosis and reduced anthracycline use. However, the characteristic changes o...
Targeted therapies in HER2-positive breast cancer with receptor-redirected Arazyme-linker-Herceptin as a novel fusion protein
Targeted therapies in HER2-positive breast cancer with receptor-redirected Arazyme-linker-Herceptin as a novel fusion protein
Targeted treatment of different types of cancers through highly expressed cancer cell surface receptors by fusion proteins...
Survival in patients with rheumatoid arthritis and early breast cancer treated with tumor necrosis factor inhibitors
Survival in patients with rheumatoid arthritis and early breast cancer treated with tumor necrosis factor inhibitors
There have been concerns about the use of tumor necrosis factor inhibitors (TNFi) for autoimmune disease in patients with ...
Case series of Li-Fraumeni syndrome: carcinogenic mechanisms in breast cancer with TP53 pathogenic variant carriers
Case series of Li-Fraumeni syndrome: carcinogenic mechanisms in breast cancer with TP53 pathogenic variant carriers
Li-Fraumeni syndrome (LFS), a hereditary condition attributed to TP53 pathogenic variants,(PV), is associated with high ri...
Identification and validation of screening models for breast cancer with 3 serum miRNAs in an 11,349 samples mixed cohort
Identification and validation of screening models for breast cancer with 3 serum miRNAs in an 11,349 samples mixed cohort
The study focuses on enhancing breast cancer (BC) prognosis through early detection, aiming to establish a non-invasive, c...
Efficacy and safety of adjuvant therapies in older patients with breast cancer: a systematic review and meta-analysis of real-world data
Efficacy and safety of adjuvant therapies in older patients with breast cancer: a systematic review and meta-analysis of real-world data
Insufficient data available for older patients with breast cancer complicates decision-making regarding optimal treatment....
Breast-conserving surgery versus modified radical mastectomy in T1-2N3M0 stage breast cancer: a propensity score matching analysis
Breast-conserving surgery versus modified radical mastectomy in T1-2N3M0 stage breast cancer: a propensity score matching analysis
Breast-conserving surgery (BCS) plus radiotherapy and mastectomy exhibit highly comparable prognoses for early-stage breas...
Quality of life in women with breast cancer undergoing neoadjuvant chemotherapy: comparison between PICC and PICC-port
Quality of life in women with breast cancer undergoing neoadjuvant chemotherapy: comparison between PICC and PICC-port
Peripherally inserted central catheters (PICCs) and new type of arm-port, the PICC-port, are currently used for neoadjuvan...